Risk factors in invasive candidiasis: Stratification;Factores de riesgo de la candidiasis invasora: Estratificación

Revista Iberoamericana de Micologia

Volumn 23, Issue 1, 2006, Pages 29-31

  Del Palacio, Amalia ^a   Alhambra, Almudena ^a   Cuetara, Ma Soledad ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Critically ill non neutropenic patients; Invasive candidiasis; Preemptive treatment; Risk factors; Stratification

Indexed keywords

CANDIDIASIS; CRITICALLY ILL PATIENT; DIAGNOSTIC PROCEDURE; HUMAN; NEUTROPENIA; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; STRATIFICATION;

EID: 32644446281     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-1406(06)70009-2     Document Type: Review

References (32)

1. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ; Invasive Fungal Infections Copperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
2. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP; National Epidemiology of Mycoses Survey (NEMIS) Study Group. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The national epidemiology of mycosis survey. Clin Infect Dis 2001; 33: 177-186.
3. Boyce JM, Pittet D. Guideline for hand hygiene in health care settings. MMWR 2002; 51: 1-45.
4. Coopersmith CM, Rebmann TL, Zack JE, Ward MR, Corcoran RM, Schallom ME, Sona CS, Buchman TG, Boyle WA, Polish LB, Fraser VJ. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intesive care unit. Crit Care Med 2002; 30: 59-64.
5. De Pauw BE, Patterson TF. Should consensus guidelines specific criteria for the diagnosis of invasive fungal infection be changed? Clin Infect Dis 2005; 41: S377-S380.
6. De Waele JJ, Vogelaers D, Blot S, Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis 2003; 37: 208-213.
7. Diekema DJ, Pfaller MA. Nosocomial candemia: an ounce of prevention is better than a pound of cure. Infect Control Hosp Epidemiol 2004; 25: 624-626.
8. Dupont H, Bourichon A, Paugam-Burtz C, Mantz J, Desmonts JM. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 2003; 31: 725-757.
9. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T. Fluconazole prophylaxis prevents intraabdominal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27: 1066-1072.
10. Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D. Prevention of severe Candida infections in non neutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002 28: 1708-1717.
11. García Ruíz JC, Amutio E, Pontón J. Infección fúngica invasora en pacientes inmunocomprometidos. Rev Iberoam Micol 2004; 21: 55-62.
12. Hoerauf A, Hammer S, Muller-Myhsok B, Rupprecht H. Intraabdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit Care Med 1998; 26: 2010-2015.
13. Jarvis WR. Epidemiology of nosocomial fungal infection, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-1530.
14. Krcmery VC, Babela R. Candidemia in the surgical Intensive Care Unit. Clin Infect Dis 2003; 34: 1536-1537.
15. Leleu G, Aegeter P, Guidet B. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002; 17: 168-175.
16. Ostrosky-Zeichner L. New approaches to the risk of Candida in the intensive care unit. Curr Opin Infect Dis 2003, 16: 533-537.
17. Ostrosky-Zeichner L. Prophylaxis and treatment of invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2004; 23: 739-744.
18. Ostrosky-Zeichner L, Sable C, Sobel J, Alexander B, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen R, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Wallace D, Rex JH. Multicenter retrospective development and validation of a clinical prediction rule for invasive candidiasis (IC) in the intensive care setting. 2004 Focus on Fungal Infections 14. Abstract 51.
19. Paphitou NI, Ostrosky-Zeichner L, Rex JH. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005; 43: 235-243.
20. Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A. Assessment of preemptive treatment to prevent sever candidiasis in critically ill surgical patients. Crit Care Med 2004; 32: 2443-2449.
21. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1944; 220: 751-758.
22. Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA. Double-blind placebo controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233: 542-548.
23. Posteraro B, Bruno S, Boccia S, Ruggiero A, Sanguinetti M, Romano Spica V, Ricciardi G, Fadda G. Candida parapsilosis bloodstream infection in pediatric oncology patients: results of an epidemiologic investigation. Infect Control Hosp Epidemiol 2004; 25: 641-645.
24. Rex JH, Sobel JD. Preventing intra-abdominal candidiasis in surgical patients. Crit Care Med 1999; 27: 1033-1034.
25. Rex JH, Sobel JD. Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 2001; 32: 1191-1200.
26. Shin JH, Kim MN, Shin DH, Jung SI, Kim KJ, Cho D, Kee SJ, Shin MG, Suh SP, Ryang DW. Genetic relatedness among Candida tropicalis isolates from sporadic cases of fungemia in two university hospitals in Korea. Infect Control Hosp Epidemiol 2004; 25: 634-640.
27. Sobel JD, Rex JH. Invasive candidiasis: turning risk into a practical prevention policy? Clin Infect Dis 2001; 33: 187-190.
28. Tran LT, Auger P, Marchand R, Carrier M, Pellitier C. Epidemiological study of Candida spp. colonization in cardiovascular surgical patients. Mycoses 1997; 40: 169-173.
29. Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nystrom PO, Pittet D, Rogers T, Sandven P, Sganga G, Schaller MD, Solomkin J. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998; 21: 206-216.
30. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995; 20: 1531-1534.
31. Wenzel RP, Gennings C. Bloodstream infections due to Candida species in the intensive care unit: identifying high-risk patients to determine prevention strategies. Clin Infect Dis 2005; 41: S389-S393.
32. Yazdanporast K, Auger P, Marchand R, Carrier M, Cartier R. Predictive value of Candida colonization index in 131 patients undergoing two different cardiovascular surgical procedures. J Cardiovas Surg 2001; 42: 339-343.